IPSEY

ABBV AMGN AMGN:CA BAYRY BAYZF Biotechnology BMY GILD IPSEF IPSEY JNJ JNJ:CA LLY LLY:CA NONOF NOVO:CA NVO NVON:CA NVS NVS:CA NVSEF PFE PFE:CA REGN RHHBF RHHBY RHHVF Robert J. Lake ROCH:CA ROG:CA SAN:CA SNY SNY:CA SNYNF Uncategorized VRTX ZLLY:CA ZPFE:CA

Regeneron: Fairly Valued Now After A Stellar Upswing

Mar 11, 2026

Biotechnology DAWN IPSEY JAZZ Uncategorized

Day One Biopharma to be acquired by Servier for $2.5B

Mar 6, 2026

ABBV ABBV:CA Biotechnology DAWN IPSEF IPSEY JAZZ LLY LLY:CA Terry Chrisomalis Uncategorized WHWK ZLLY:CA

Day One Biopharmaceuticals: ‘Strong Buy,’ Several 2026 Milestones In Play Plus OJEMDA Growth

Mar 5, 2026

Biotechnology DAWN IPSEY JAZZ Uncategorized

Day One Biopharmaceuticals gains amid takeover speculation

Mar 4, 2026

ALLKA Research Biotechnology GILD GILD:CA GLAXF GNFTF GNFTY GSK IPSEF IPSEY JNJ JNJ:CA MRK MRK:CA Uncategorized

Time To Take Profits On Gilead Sciences (Rating Downgrade)

Feb 20, 2026

Biotechnology GNFTF GNFTY IPSEF IPSEY Uncategorized

Genfit adds $20M as Ipsen records strong sales for liver drug

Feb 12, 2026